col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer Science and Business Media LLC: Cellular and Molecular Immunology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―21 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection Alberto Pérez-Gómez, Joana Vitallé, Carmen Gasca-Capote, Alicia Gutierrez-Valencia, María Trujillo-Rodriguez, Ana Serna-Gallego, et al. (+112)
2 [GO] 2021―Jul―19 Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19 Xiuying Mu, Kai Liu, Huajie Li, Fu-Sheng Wang, Ruonan Xu
3 [GO] 2021―Jul―19 Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles Xiantao Zhang, Yaochang Yuan, Bolin Wu, Xuemei Wang, Yingtong Lin, Yuewen Luo, et al. (+7)
4 [GO] 2021―Jul―15 SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients Yao Deng, Yu Li, Ren Yang, Wenjie Tan
5 [GO] 2021―Jun―09 Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis Bo Huang
6 [GO] 2021―Jun―07 Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection Hao Wang, Yu Yuan, Mingzhong Xiao, Li Chen, Youyun Zhao, Pinpin Long, et al. (+21)
7 [GO] 2021―May―31 Cross-reactive antibody immunity against SARS-CoV-2 in children and adults Elizabeth Fraley, Cas LeMaster, Dithi Banerjee, Santosh Khanal, Rangaraj Selvarangan, Todd Bradley
8 [GO] 2021―May―31 Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2 Huiqing Xiu, Jiali Gong, Tiancha Huang, Yanmei Peng, Songjie Bai, Guirun Xiong, et al. (+4)
9 [GO] 2021―May―10 IL-33 in COVID-19: friend or foe? Yuejin Liang, Yiyue Ge, Jiaren Sun
10 [GO] 2021―May―06 Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein-ACE2 interaction MengYa Yuan, YaoYing Wan, Cui Liu, Yue Li, ZhaoYuan Liu, ChangDong Lin, JianFeng Chen
11 [GO] 2021―Apr―01 ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques Jiadi Lv, Pin Yu, Zhenfeng Wang, Wei Deng, Linlin Bao, Jiangning Liu, et al. (+12)
12 [GO] 2021―Mar―19 Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm Jinghe Zhang, Haibo Wu, XiaoHong Yao, Dingyu Zhang, Yonggang Zhou, Binqing Fu, et al. (+9)
13 [GO] 2021―Mar―17 Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice Shihui Sun, Lei He, Zhongpeng Zhao, Hongjing Gu, Xin Fang, Tiecheng Wang, et al. (+22)
14 [GO] 2021―Mar―04 Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution Huan Qi, Ming-liang Ma, He-wei Jiang, Jian-ya Ling, Ling-yun Chen, Hai-nan Zhang, et al. (+13)
15 [GO] 2021―Feb―26 Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients Penghui Yang, Yingze Zhao, Jie Li, Chuanyu Liu, Linnan Zhu, Jie Zhang, et al. (+22)
16 [GO] 2021―Feb―26 SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation Wenjing Wang, Zhuo Zhou, Xia Xiao, Zhongqin Tian, Xiaojing Dong, Conghui Wang, et al. (+5)
17 [GO] 2021―Feb―25 Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies Jie Hu, Pai Peng, Kai Wang, Liang Fang, Fei-yang Luo, Ai-shun Jin, et al. (+3)
18 [GO] 2021―Feb―13 Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, et al. (+4)
19 [GO] 2021―Feb―13 Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice Wenjun Wang, Baoying Huang, Yanping Zhu, Wenjie Tan, Mingzhao Zhu
20 [GO] 2021―Jan―22 Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients Yang Li, Dan-yun Lai, Qing Lei, Zhao-wei Xu, Feng Wang, Hongyan Hou, et al. (+27)
21 [GO] 2021―Jan―20 Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response Zengguo Cao, Hongjie Xia, Ricardo Rajsbaum, Xianzhu Xia, Hualei Wang, Pei-Yong Shi
22 [GO] 2021―Jan―14 SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19 Victor M. Arce, Jose A. Costoya
23 [GO] 2021―Jan―11 COVID-19 and flu: conserved or specific immune signature? Christophe Paget, François Trottein
24 [GO] 2021―Jan―08 Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months Pai Peng, Jie Hu, Hai-jun Deng, Bei-zhong Liu, Liang Fang, Kai Wang, et al. (+2)
25 [GO] 2021―Jan―08 The interplay between dendritic cells and CD8 T lymphocytes is a crucial component of SARS-CoV-2 immunity Jonas Buttenschön, Jochen Mattner
26 [GO] 2021―Jan―06 A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity Vincent Legros, Solène Denolly, Manon Vogrig, Bertrand Boson, Eglantine Siret, Josselin Rigaill, et al. (+16)
27 [GO] 2020―Dec―14 Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients Xixiang Ma, Chuhuai Guan, Rong Chen, Yunyun Wang, Shenglei Feng, Rongshuai Wang, et al. (+8)
28 [GO] 2020―Dec―14 Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment Alejandra Gomez-Cadena, Laurie Spehner, Marie Kroemer, Myriam Ben Khelil, Kevin Bouiller, Grégory Verdeil, et al. (+4)
29 [GO] 2020―Nov―26 New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein Junzhi Wang
30 [GO] 2020―Nov―02 Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods Berislav Bošnjak, Saskia Catherina Stein, Stefanie Willenzon, Anne Katrin Cordes, Wolfram Puppe, Günter Bernhardt, et al. (+16)
31 [GO] 2020―Oct―27 SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response Yu-Zhi Fu, Su-Yun Wang, Zhou-Qin Zheng, Wei-Wei Li, Zhi-Sheng Xu, Yan-Yi Wang
32 [GO] 2020―Oct―15 Unique immunological profile in patients with COVID-19 Stefania Varchetta, Dalila Mele, Barbara Oliviero, Stefania Mantovani, Serena Ludovisi, Antonella Cerino, et al. (+8)
33 [GO] 2020―Oct―09 A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract Fengyu Hu, Fengjuan Chen, Zhihua Ou, Qinghong Fan, Xinghua Tan, Yaping Wang, et al. (+16)
34 [GO] 2020―Oct―02 Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients Meijuan Zheng, Yong Gao, Siyu Liu, Dandan Sun, Fan Yang, Lu Zong, et al. (+4)
35 [GO] 2020―Sep―17 Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies Bingfeng Liu, Yaling Shi, Wanying Zhang, Rong Li, Zhangping He, Xiaofan Yang, et al. (+13)
36 [GO] 2020―Sep―11 Low glycosylated ferritin is a sensitive biomarker of severe COVID-19 Maxime Fauter, Sébastien Viel, Sabine Zaepfel, Pierre Pradat, Julie Fiscus, Marine Villard, et al. (+5)
37 [GO] 2020―Sep―11 Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019 Lan Huang, Xuan Zhao, Yu Qi, Hong Li, Guanchao Ye, Yafei Liu, et al. (+2)
38 [GO] 2020―Sep―07 Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients Yang Li, Dan-yun Lai, Hai-nan Zhang, He-wei Jiang, Xiaolong Tian, Ming-liang Ma, et al. (+11)
39 [GO] 2020―Sep―03 Expansion of atypical memory B cells is a prominent feature of COVID-19 Barbara Oliviero, Stefania Varchetta, Dalila Mele, Stefania Mantovani, Antonella Cerino, Cesare G. Perotti, et al. (+2)
40 [GO] 2020―Jul―29 Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient Guillaume Monneret, Donatien de Marignan, Rémy Coudereau, Céline Bernet, Florence Ader, Emilie Frobert, et al. (+4)
41 [GO] 2020―Jul―29 SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 He-wei Jiang, Hai-nan Zhang, Qing-feng Meng, Jia Xie, Yang Li, Hong Chen, et al. (+7)
42 [GO] 2020―Jul―10 Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, et al. (+4)
43 [GO] 2020―Jul―03 Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients Liting Chen, Xiaolu Long, Qian Xu, Jiaqi Tan, Gaoxiang Wang, Yang Cao, et al. (+19)
44 [GO] 2020―Jul―01 Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 Olivier Demaria, Julien Carvelli, Luciana Batista, Marie-Laure Thibult, Ariane Morel, Pascale André, et al. (+3)
45 [GO] 2020―Jun―25 Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients Yaguang Zhang, Xiaojing Wang, Xuezhen Li, Dong Xi, Ruizhi Mao, Xiaohui Wu, et al. (+9)
46 [GO] 2020―Jun―18 The ORF3a protein of SARS-CoV-2 induces apoptosis in cells Yujie Ren, Ting Shu, Di Wu, Jingfang Mu, Chong Wang, Muhan Huang, et al. (+5)
47 [GO] 2020―Jun―15 Systemically comparing host immunity between survived and deceased COVID-19 patients Feng Wang, Hongyan Hou, Yin Yao, Shiji Wu, Min Huang, Xiao Ran, et al. (+3)
48 [GO] 2020―May―28 Serum IgA, IgM, and IgG responses in COVID-19 Huan Ma, Weihong Zeng, Hongliang He, Dan Zhao, Dehua Jiang, Peigen Zhou, et al. (+4)
49 [GO] 2020―May―28 More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells Ger Rijkers, Trees Vervenne, Pieter van der Pol
50 [GO] 2020―May―15 Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, et al. (+9)
51 [GO] 2020―May―12 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Chao Zhang, Fu-Sheng Wang, Jean-Sébastien Silvestre, Fernando Arenzana-Seisdedos, Hong Tang
52 [GO] 2020―May―07 NKG2A and COVID-19: another brick in the wall Luca Antonioli, Matteo Fornai, Carolina Pellegrini, Corrado Blandizzi
53 [GO] 2020―May―07 Protective humoral immunity in SARS-CoV-2 infected pediatric patients Yaguang Zhang, Jin Xu, Ran Jia, Chunyan Yi, Wangpeng Gu, Pengcheng Liu, et al. (+14)
54 [GO] 2020―Apr―28 High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients Wenjing Wang, Bin Su, Lijun Pang, Luxin Qiao, Yingmei Feng, Yabo Ouyang, et al. (+7)
55 [GO] 2020―Apr―20 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor Xiangyu Chen, Ren Li, Zhiwei Pan, Chunfang Qian, Yang Yang, Renrong You, et al. (+18)
56 [GO] 2020―Apr―07 SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, et al. (+4)
57 [GO] 2020―Mar―31 COVID-19: a new challenge for human beings Penghui Yang, Xiliang Wang
58 [GO] 2020―Mar―19 Functional exhaustion of antiviral lymphocytes in COVID-19 patients Meijuan Zheng, Yong Gao, Gang Wang, Guobin Song, Siyu Liu, Dandan Sun, et al. (+2)
59 [GO] 2020―Mar―19 Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, et al. (+2)
60 [GO] 2020―Mar―17 Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients Hong-Yi Zheng, Mi Zhang, Cui-Xian Yang, Nian Zhang, Xi-Cheng Wang, Xin-Ping Yang, et al. (+2)
61 [GO] 2020―Mar―04 Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV Ming Zheng, Lun Song
62 [GO] 2020―Feb―24 Epitopes for a 2019-nCoV vaccine Guglielmo Lucchese
63 [GO] 2020―Feb―11 Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein Shuai Xia, Yun Zhu, Meiqin Liu, Qiaoshuai Lan, Wei Xu, Yanling Wu, et al. (+5)
64 [GO] 2020―Feb―05 A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome Shibo Jiang, Shuai Xia, Tianlei Ying, Lu Lu


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.016 sec